Expression of SRP-9001 dystrophin and stabilization of motor function up to 2 years post-treatment with delandistrogene moxeparvovec gene therapy in individuals with Duchenne muscular dystrophy
- Resource Type
- article
- Source
- Frontiers in Cell and Developmental Biology, Vol 11 (2023)
- Subject
Duchenne muscular dystrophy gene therapy dystrophin AAVrh74 SRP-9001 Biology (General) QH301-705.5 - Language
- English
- ISSN
- 2296-634X